Xenotransplantation literature update

Xenotransplantation

Volumn 4, Issue 2, 1997, Pages 120-125

  Auchincloss Jr , Hugh ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0344294169     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3089.1997.tb00174.x     Document Type: Review

References (128)

1. LIN SS, PLATT JL. Immunologic barriers to xenotransplantation. J Heart Lung Transplant 1996:15:547-555.
2. LAWSON JH, PLATT JL. Molecular barriers to xenotransplantation. Transplantation 1996:62:303-310.
3. PLATT JL. The immunological barriers to xenotransplantation. Crit Rev Immunol 1996:16:331-358.
4. PLATT JL. Xenotransplantation: recent progress and current perspectives. Curr Opin Immunol 1996:8:721-728.
5. SYKES M. Immunobiology of transplantation. FASEB 1996:10:721-730.
6. KEMP E. Xenotransplantation. J Intern Med 1996:239: 287-297.
7. MINANOV OP, ITESCU S, MICHLER RE. Recent advances and the potential for clinical use of xenotransplantation. Curr Opin Cardiol 1996:11:214-220.
8. AZIMZADEH A, MEYER C, RAVANAT C, CAZENAVE JP, WOLF P. Xenograft rejection: Molecular mechanisms and therapeutic prospects. Hematol Cell Ther 1996:38:331-343.
9. WARRENS AN, DORLING A, LECHLER RI. The prospects for xenotransplantation. QJM 1996:89:885-891.
10. SABLINSKI T. Xenotransplantation: Lessons from nature. Xenotransplantation 1996:3:275-278.
11. COOPER DKC. Ethical aspects of xenotransplantation of current importance. Xenotransplantation 1996:3:264-274.
12. COOPER DK. Xenotransplantation: Benefits, risks and regulation. Ann R Coll Surg Engl 1996:78:92-96.
13. MICHLER RE. Xenotransplantation: Risks and prospects. Xeno 1996:4:21-26.
14. MICHLER RE. Xenotransplantation: Risks, clinical potential, and future prospects. Emerg Infect Dis 1996:2:64-70.
15. ALLAN JS. Xenotransplantation at a crossroads: Prevention versus progress. Nat Med 1996:2:18-21.
16. SELLS RA. On the ethics of xenotransplants. Xeno 1996:4:18-20.
17. WADMAN M. Xenotransplantation trails 'should proceed but need guidelines.' Nature 1996:382:197.
18. CHASTEL CE. The dilemma of xenotransplantation. Emerg Infect Dis 1996:2:155.
19. BLOCK G. Another opinion on xenotransplantation. J Am Vet Med Assoc 1996:208:1788-1789.
20. MCKENZIE IF. Yes to transplants. Nature 1996:380:478.
21. NICHOLSON RH. This little pig went to market. Hastings Cent Rep 1996:26:3.
22. SWINDLE MM. Considerations of specific pathogen-free swine (SPF) in xenotransplantation. J Invest Surg 1996:9:267-271.
23. ILDSTAD ST. Xenotransplantation for AIDS. Lancet 1996:347:761.
24. FRICKER J. Baboon xenotransplant fails but patient improves. Lancet 1996:347:457.
25. CRAMER DV, WU GW. The humoral response to xenografts. Xeno 1996:4:30-34.
26. KEARNS-JONKER M, CRAMER DV, FRAIMAN M, MIDDLETON Y, SHIRWAN A, SWENSSON J, WU GD, MAKOWKA L. Identification and characterization of monoclonal antibodies that partially block human natural antibody binding to pig endothelial cell xenoantigens. Xenotransplantation 1996:3:287-295.
27. SNAPPER CM, MOND JJ. A model for induction of T cell-independent humoral immunity in response to polysaccharide antigens. J Immunol 1996:157:2229-2233.
28. NAZIRUDDIN B, SHIROKI R, SHISHIDO S, HOWARD T, MOHANAKUMAR T. Biochemical and functional characterization of xenoreactive natural antibodies in hu-PBL-SCID mice. J Clin Invest 1996:97:1267-1275.
29. Yu PB, HOLZKNECHT ZE, BRUNO D, PARKER W, PLATT JL. Modulation of natural IgM binding and complement activation by natural IgG antibodies. J Immunol 1996:157: 5163-5168.
30. ROSE AG, COOPER DK. A histopathologic grading system of hyperacute (humoral, antibody-mediated) cardiac xenografts and allograft rejection. J Heart Lung Transplant 1996:15:804-817.
31. RICHARDS AC, TUCKER AW, CARRINGTON CA, WHITE DJ, WALLWORK JD. Neutrophils and xenotransplantation. Lancet 1996:348:1596.
32. AL-MOHANNA FA, COLLISON KS, ALLEN SP, STERN D, YACOUB MH. Naive neutrophils and xenotransplantation. Lancet 1996:348:1246.
33. HENGSTER P, LINKE R, FEICHTINGER J, HECHENLEITNER P, MARK W, EBERL T, KLIMA G, HUEMER H, DAHA M, MARGREITER R. Mechanisms of hyperacute rejection of discordant liver xenograft. Xenotransplantation 1996: 3:246-251.
34. SCHRAA EO, SCHOTMAN SN, SCHERINGA M, DAHA MR, MARGUET RL, IJZERMANS JNM. Discordant liver transplantation in the guinea pig to rat model does not lead to classical hyperacute rejection. Xenotransplantation 1996: 3:321-327.
35. CATTAN P, ZHANG B, BRAET F, ATIA N, CONTI F, CONJEAUD H, WEILL B, CHEREAU C, HOUSSIN D, CALMUS Y. Comparison between aortic and sinusoidal liver endothelial cells as targets of hyperacute xenogeneic rejection in the pig to human combination. Transplantation 1996:62:803-810.
36. BREIMER ME, BJORCK S, SVALANDER CT, BENGTSSON A, RYDBERG L, LIE-KARLSEN K, ATTMAN P-O, AURELL M, SAMUELSSON BE. Extracorporeal ("ex vivo") connection of pig kidneys to humans. I. Clinical data and studies of platelet destruction. Xenotransplantation 1996:3:328-339.
37. VETR H, LIPP J. Tumor necrosis factor-induced expression of porcine glycoproteins GP65 and GP100 recognized by human xenoreactive natural antibodies. Transplantation 1996:62:396-402.
38. COOPER DKC, CAIRNS TDH, TAUBE DH. Extracorporeal immunoadsorption of αGal antibodies. Xeno 1996:4:27-29.
39. TANIGUCHI S, NEETHLING FA, KORCHAGINA EY, BOVIN N, YE Y, KOBAYASHI T, NIEKRASZ M, LI S, KOREN E, ORIOL R, COOPER DKC. In vivo immunoadsorption of antipig antibodies in baboons using a specific Galα1-3Gal column. Transplantation 1996:62:1379-1384.
40. KOREN E, MILOTIC F, NEETHLING FA, KOSCEC M, FEI D, KOBAYASHI T, TANIGUCHI S, COOPER DKC. Monoclonal antiidiotypic antibodies neutralize cytotoxic effects of anti-αGal antibodies. Transplantation 1996:62:837-843.
41. GALILI U, MATTA KL. Inhibition of anti-Gal IgG binding to porcine endothelial cells by synthetic oligosaccharides. Transplantation 1996:62:256-262.
42. KOJIMA T, HAYASHI S, YOKOYAMA I, TAKAGI H. Role of Fc fragments in inhibition of xenogenic hyperacute rejection by intravenous immunoglobulin. Transplantation 1996:62:559-562.
43. KROSHUS TJ, BOLMAN RM III, DALMASSO AP. Selective IgM depletion prolongs organ survival in an ex vivo model of pig-to-human xenotransplantation. Transplantation 1996:62:5-12.
44. LI SF, NEETHLING FA, TANIGUCHI S, YEH JC, KOBAYASHI T, YE Y, KOREN E, CUMMINGS RD, COOPER DKC. Glycans derived from porcine stomach mucin are effective inhibitors of natural anti-α-Galactosyl antibodies in vitro and after intravenous infusion in baboons. Transplantation 1996:62:1324-1331.
45. WATIER H, GUILLAUMIN J-M, PILLER F, LACORD M, THIBAULT G, LEBRANCHU Y, MONSIGNY M, BARDOS P. Removal of terminal α-Galactosyl residues from xenogeneic porcine endothelial cells: Decrease in complement-mediated cytotoxicity but persistence of IgG1-mediated antibody-dependent cell-mediated cytotoxicity. Transplantation 1996:62:105-113.
46. DAVIS EA, PRUITT SK, GREENE PS, IBRAHIM S, LAM TT, LEVIN JL, BALDWIN WM III, SANFILIPPO F. Inhibition of complement, evoked antibody, and cellular response prevents rejection of pig-to-primate cardiac xenografts. Transplantation 1996:62:1018-1023.
47. CANDINAS D, LESNIKOSKI BA, ROBSON SC, MIYATAKE T, SCESNEY SM, MARSH JR HC, RYAN US, DALMASSO AP, HANCOCK WW, BACH FH. Effect of repetitive high-dose treatment with soluble complement receptor type 1 and cobra venom factor on discordant xenograft survival. Transplantation 1996:62:336-342.
48. HECKL-OSTREICHER B, WOSNIK A, KIRSCHFINK M. Protection of porcine endothelial cells from complement-mediated cytotoxicity by the human complement regulators CD59, C1 inhibitor, and soluble complement receptor type 1. Transplantation 1996:62:1693-1696.
49. KOBAYASHI T, NEETHLING FA, TANIGUCHI S, YE Y, NIEKRASZ M, KOREN E, HANCOCK WW, TAKAGI H, COOPER DKC. Investigation of the anti-complement agents, FUT-175 and K76COOH, in discordant xenotransplantation. Xenotransplantation 1996:3:237-245.
50. RAJASINGHE HA, REDDY VM, HANCOCK WW, SAYEGH MH, HANLEY FL. Key role of the alternate complement pathway in hyperacute rejection of rat hearts transplanted into fetal sheep. Transplantation 1996:62:407-426.
51. SANFILIPPO F. Exogenous complement inhibition in xenotransplantation. Xeno 1996:4:46-49.
52. TANIGUCHI S, KOBAYASHI T, NEETHLING FA, YE Y, NIEKRASZ M, WHITE DJG, COOPER DKC. Cobra venom factor stimulates anti-α-Galactose antibody production in baboons. Transplantation 1996:62:678-681.
53. MULDER LCF, MORA M, LAZZERI M, BOSCHI M, CICCOPIEDI E, MELLI C, BRUZZONE P, ALFANI D, CORTESINI R, ROSSINI M. Human MCP and DAF double transgenic mice are protected from human complement attack in an in vivo model. Trans Proc 1996:28:589.
54. PLATT JL, LOGAN JS. Transgenic animals expressing human complement regulatory proteins. Xeno 1996:4:4-7.
55. SCHMOECKEL M, NOLLERT G, SHAHMOHAMMADI M, YOUNG VK, CHAVEZ G, KASPER-KONIG W, WHITE DJG, MULLER-HOCKER J, ARENDT RM, WILBERT-LAMPEN U, HAMMER C, REICHART B. Prevention of hyperacute rejection by human decay accelerating factor in xenogeneic perfused working hearts. Transplantation 1996:62:729-734.
56. VAN DENDEREN BJW, PEARSE MJ, AMINIAN A, ADAM W, SHINKEL TA, D'APICE AJF. Decay-accelerating factor transgenic mouse hearts are protected from human complement-mediated attack. Trans Proc 1996:28:583-584.
57. WHITE DJG. hDAF transgenic pig organs: Are they concordant for human transplantation? Xeno 1996:4:50-54.
58. WHITE DJ, YANNOUTSOS N. Production of pigs transgenic for human DAF to overcome complement-mediated hyperacute xenograft rejection in man. Res Immunol 1996:147:88-94.
59. BRAIDLEY P, ARAVOT D, HUNTER S, DUNNING J, WHITE D, WALLWORK J. Transgenic pigs - breakthrough in xenotransplantation. Isr J Med Sci 1996:32:795-798; discussion 1052.
60. HOOPES CW, PLATT JF. Molecular strategies for clinical xenotransplantation in cardiothoracic surgery. Semin Thorac Cardiovasc Surg 1996:8:156-174.
61. CANDINAS D, LESNIKOSKI B-A, HANCOCK WW, OTSU I, KOYAMADA N, DALMASSO AP, ROBSON SC, BACH FH. Inhibition of platelet integrin GPIIbIIIa prolongs survival of discordant cardiac xenografts. Transplantation 1996:62:1-5.
62. KOYAMADA N, MIYATAKE T, CANDINAS D, HECHENLEITNER P, SIEGEL J, HANCOCK WW, BACH FH, ROBSON SC. Apyrase administration prolongs discordant xenograft survival. Transplantation 1996:62:1739-1743.
63. COWAN PJ, SHINKEL TA, WITORT FJ, BARLOW H, PEARSE MJ, D'APICE AJF. Targeting gene expression to endothelial cells in transgenic mice using the human intercellular adhesion molecule 2 promoter. Transplantation 1996:62:155-160.
64. TANIGUCHI S, NEETHLING FA, ORIOL R, KOBAYASHI T, YE Y, NIEKRASZ M, PETERS L, KOSANKE S, KOREN E, COOPER DKC. Ratites (ostrich, emu) as potential heart donors for humans: Immunologic, anatomic, and physiologic considerations. Xenotransplantation 1996:3:252-259.
65. MICHLER RE, SHAH AS, ITESCU S, O'HAIR DP, TUGULEA S, KWIATKOWSKI PA, LIU Z, PLATT JL, ROSE EA, SUCIU-FOCA N. The influence of concordant xenografts on the humoral and cell-mediated immune responses to subsequent allografts in primates. J Thorac Cardiovasc Surg 1996:112:1002-1009.
66. MATSUMIYA G, GUNDRY SR, FUKUSHIMA N, KAWAUCHI M, ZUPPAN CW, BAILEY LL. Pediatric cardiac xenograft growth in a rhesus monkey-to-baboon transplantation model. Xenotransplantation 1996:3:76-80.
67. CHONG ASF, SHEN J, XIAO F, BLINDER L, WEI L, SANKARY H, FOSTER P, WILLIAMS J. Delayed xenograft rejection in the concordant hamster heart into Lewis rat model. Transplantation 1996:62:90-96.
68. STEINBRUCHEL DA. Pathogenesis and mechanisms of graft rejection in concordant xenotransplantation with special reference to hamster-to-rat cardiac transplantation. APMIS Suppl 1996:58:5-45.
69. NAGAYASU T, KAWAHARA K, TAKAHASHI T, YAMAMOTO S, AYABE H. Concordant lung xenograft rejection in a hamster-to-rat model. Surg Today 1996:26:793-799.
70. NAGAYASU T, KAWAHARA T, TAKAHASHI T, IDE S, SASAKI N, SHINGU H, YAMAMOTO S, YAMASAKI N, AYABE H. Prolongation of lung xenograft survival in rats with a short course of deoxyspergualin and cyclosporin A. Transpl Int 1996:9:184-193.
71. SALOMON S, STEINBRUCHEL D, NIELSEN B, KEMP E. Hamster to rat kidney transplantation: technique, functional outcome and complications. Urol Res 1996:24:211-216.
72. LIN Y, WAER M. In vivo mechanism of action of Leflunomide: Selective inhibition of the capacity of B lymphocytes to make T-independent xenoantibodies. Trans Proc 1996:28:3085.
73. TISSOT JD, SCHNEIDER P, SCHAPIRA M, DUCHOSAL MA. Human immunoglobulins produced in hu-PBL-SCID mice are polyclonal early after xenotransplantation. Cell Immunol 1996:167:241-248.
74. KOMATSU K, YOUM W, KONISHI H, KAWAHARADA N, YOUSEM SA, MURASE N, GRIFFITH BP, PHAM SM. Prolonged survival of hamster-to-rat pulmonary xenografts by tacrolimus (FK506) and cyclophosphamide. J Heart Lung Transplant 1996:15:722-727.
75. RYDBERG L, BJORCK S, HALLBERG E, MAGNUSSON S, SUMITRAN S, SAMUELSSON BE, STROKAN V, SVALANDER CT, BREIMER ME. Extracorporeal ("ex vivo") connection of pig kidneys to humans. II. The anti-pig antibody response. Xenotransplantation 1996:3:340-353.
76. FRYER JP, CHEN S, JOHNSON EM, SIMONE P, MATAS AJ. The role of macrophages in endothelial cell injury - a possible mechanism for delayed xenograft rejection. Trans Proc 1996:28:626.
77. GOODMAN DJ, VON ALBERTINI MA, MCSHEA A, WRIGHTON CJ, BACH FH. Adenoviral-mediated overexpression of IκBα in endothelial cells inhibits natural killer cell-mediated endothelial cell activation. Transplantation 1996:62:967-972.
78. GREY ST, HANCOCK WW. A physiologic anti-inflammatory pathway based on thrombomodulin expression and generation of activated protein C by human mononuclear phagocytes. J Immunol 1996:156:2256-2263.
79. JURD KM, GIBBS RV, HUNT BJ. Activation of human prothrombin by porcine aortic endothelial cells - a potential barrier to pig to human xenotransplantation. Blood Coagul Fibrinolysis 1996:7:336-343.
80. DORLING A, STOCKER C, TSAO T, HASKARD DO, LECHLER RI. In vitro accommodation of immortalized porcine endothelial cells: Resistance to complement mediated lysis and down-regulation of VCAM expression induced by low concentrations of polyclonal human IgG antipig antibodies. Transplantation 1996:62:1127-1136.
81. HECHENLEITNER P, MARK W, CANDINAS D, MIYATAKE T, KOYAMADA N, HANCOCK WW, BACH FH. Protective genes expressed in endothelial cells of second hamster heart transplants to rats carrying an accommodated first graft. Xenotransplantation 1996:3:279-286.
82. ALLAIRE E, MANDET C, BRUNEVAL P, BENSENANE S, BECQUEMIN JP, MICHEL JB. Cell and extracellular matrix rejection in arterial concordant and discordant xenografts in the rat. Transplantation 1996:62:794-803.
83. FRYER JP, CHEN S, JOHNSON EM, SUN LH, MATAS AJ. The different influences of allosensitization and xenosensitization on cellular rejection. Transplant Proc 1996:28:674.
84. HAGIHARA M, SHBIURA T, TAKEBE K, MUNKHBAT B, SATO T, TSUCHIDA F, SATO K, TSUJI K. Xenogeneic iso-skin graft and mixed lymphocyte reaction studies using HLA-DP transgenic mice. Transplant Immunology 1996:4:220-226.
85. SCHERINGA M, ALWAYN IPJ, BOUWMAN E, IJZERMANS JNM, VAN BOCKEL JH, MARQUET RL. Aorta transplantation as a model to study hyperacute, acute, and chronic rejection to xenografts. Xenotransplantation 1996:3:231-236.
86. SCHERINGA M, ALWAYN IPJ, MARQUET RL. Chronic rejection after xenotransplantation. Xeno 1996:4:13-14.
87. SCHERINGA M, BUCHNER B, DE BRUIN RWF, GEERLING RA, MELIEF MJ, MULDER AH, SCHRAA EO, IJZERMANS JNM, MARQUET RL. Chronic rejection of concordant aortic xenografts in the hamster-to-rat model. Transplant Immunol 1996:4:192-197.
88. YEDIDAG EN, FRYER JP, LEVI E, BUCKINGHAM FC, IVANCIC D, KRAFF J, HUANG CF, RADEMAKER AW, KAUFMAN DB, ABECASSIS M, STUART FP. Early histopathology of small intestinal discordant xenografts. Transplantation 1996:62: 1385-1391.
89. YAMATAKA A, KATO Y, FUJIWARA T, YAGITA H, OKUMURA K, SUNAGAWA M, NOZAWA M, MIYANO T. Impact of antibodies to leukocyte function-associated antigen-1 and intercellular adhesion molecule-1 on fetal bowel allo- and xenotransplantation in mice. Transplant Proc 1996:28: 2494-2495.
90. KORSGREN O, KARLSTEN R, SUNDLER F, JANSSON L. Blood flow regulation in the transplanted fetal endocrine pancreas: Acquisition of a nitric oxide-dependent glucose-induced increase in blood flow. Transplantation 1996:61: 772-777.
91. PLATT JL. Islet xenotransplantation: How sweet it is. J Clin Invest 1996:98:1273-1274.
92. SCHAAPHERDER AFM, WOLVEKAMP MCJ, TE BULTE MTJ, BOUWMAN E, GOOSZEN HG, DAHA MR. Porcine islet cells of Langerhans are destroyed by human complement and not by antibody-dependent cell-mediated mechanisms. Transplantation 1996:62:29-33.
93. BENDA B, KARLSSON-PARRA A, RIDDERSTAD A, KORSGREN O. Xenograft rejection of porcine islet-like cell clusters in immunoglobulin- or Fc-receptor γ-deficient mice. Transplantation 1996:62:1207-1211.
94. GALPERN WR, BURNS LH, DEACON TW, DINSMORE J, ISACSON O. Xenotransplantation of porcine fetal ventral mesencephalon in a rat model of Parkinson's disease: Functional recovery and graft morphology. Exp Neurol 1996:140:1-13.
95. WOOD MJ, SLOAN DJ, WOOD KJ, CHARLTON HM. Indefinite survival of neural xenografts induced with anti-CD4 monoclonal antibodies. Neuroscience 1996:70:775-789.
96. SUN Y, MA X, ZHOU D, VACEK I, SUN AM. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J Clin Invest 1996:98:1417-1422.
97. MAKI T, O'NEIL JJ, PORTER J, MULLON CJP, SOLOMON BA, MONACO AP. Porcine islets for xenotransplantation. Transplantation 1996:62:136-138.
98. MAKI T, OTSU I, O'NEIL JJ, DUNLEAVY K, MULLON CJ, SOLOMON BA, MONACO AP. Treatment of diabetes by xenogeneic islets without immunosuppression. Use of a vascularized bioarticificial pancreas. Diabetes 1996:45: 342-347.
99. TUN T, INOUE K, HAYASHI H, AUNG T, GU YJ, DOI R, KAJI H, ECHIGO Y, WANG WJ, SETOYAMA H, IMAMURA M, MAETANI S, MORIKAWA N, IWATA H, IKADA Y. A newly developed three-layer agarose microcapsule for a promising biohybrid artificial pancreas: Rat to mouse xenotransplantation. Cell Transplant 1996:5:59-63.
100. MIYOSHI Y, DATE I, OHMOTO T, IWATA H. Histological analysis of microencapsulated dopamine-secreting cells in agarose/poly(styrene sulfonic acid) mixed gel xenotransplanted into the brain. Exp Neurol 1996:138:169-175.
101. KESSLER L, JESSER C, LOMBARD Y, KARSTEN V, BELCOURT A, PINGET M, POINDRON P. Cytotoxicity of peritoneal murine macrophages against encapsulated pancreatic rat islets: In vivo and in vitro studies. J Leukoc Biol 1996:60:729-736.
102. BIRMELE B, THIBAULT G, NIVET H, GRUEL Y, BARDOS P, LEBRANCHU Y. Human lymphocyte adhesion to xenogeneic porcine endothelial cells: Modulation by human TNF-α and involvement of VLA-4 and LFA-1. Transplant Immunol 1996:4:265-270.
103. BOYSON JE, SHUFFLEBOTHAM C, CADAVID LF, URVATER JA, KNAPP LA, HUGHES AL, WATKINS DI. The MHC class I genes of the rhesus monkey: Different evolutionary histories of MHC class I and II genes in primates. J Immunol 1996:156:4656-4665.
104. LEE JK, SCHOOK LB, RUTHERFORD MS. Porcine alveolar macrophage Mac-1 (CD11b/CD18) adhesion molecule expression. Xenotransplantation 1996:3:304-311.
105. MAHER SE, KARMANN K, MIN W, HUGHES CCW, POBER JS, BOTHWELL ALM. Porcine endothelial CD86 is a major costimulator of xenogeneic human T cells: Cloning, sequencing, and functional expression in human endothelial cells. J Immunol 1996:157:3838-3844.
106. SMYTH MJ, SUTTON VR, KERSHAW MH, TRAPANI JA. Xenospecific cytotoxic T lymphocytes use perforin- and Fas-mediated lytic pathways. Transplantation 1996:62: 1529-1532.
107. BALLAS ZK, RASMUSSEN WL, KRIEG AM. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol 1996:157:1840-1845.
108. LAZETIC S, CHANG C, HOUCHINS JP, LANIER LL, PHILLIPS JH. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol 1996:157:4741-4745.
109. MALYGUINE AM, SAADI S, PLATT JL, DAWSON JR. Differential expression of natural killer cell markers: Human versus baboon. Transplantation 1996:62: 1319-1324.
110. WATIER H, GULLAUMIN JM, VALLEE I, THIBAULT G, GRUEL Y, LEBRANCHU Y, BARDOS P. Human NK cell-mediated direct and IgG-dependent cytotoxicity against xenogeneic porcine endothelial cells. Transplant Immunol 1996:4: 293-299.
111. HAMMER C. Immunosuppression in xenotransplantation. Trans Proc 1996:28:3017-3020.
112. HALE DA, GOTTSCHALK R, FUKUZAKI T, WOOD ML, MAKI T, MONACO AP. Extended skin allo- and xenograft survival in mice treated with Rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion. Transplant Proc 1996:28:3269.
113. SCHORLEMMER HU, KURRLE R. Control of mouse-to-rat skin xenograft rejection by malononitrilamides. Transplant Proc 1996:28:3037-3039.
114. FOSTER PF, KOCISS K, SHEN J, SANKARY HN, XIAO F, WILLIAMS JW. Lefunomide and cyclosporine immunomodulation in intestinal xenotransplantation. Transplant Proc 1996:28:2527-2528.
115. LIN Y, SEGERS C, WAER M. Efficacy of the malononitrilamide X 920715 as compared with leflunomide in cardiac allo-and xenotransplantation in rats. Transplant Proc 1996: 28:3036.
116. BENELLI U, LEPRI A, DEL TACCA M, NARDI M. FK-506 delays corneal graft rejection in a model of corneal xenotransplantation. J Ocul Pharmacol Ther 1996:12: 425-431.
117. ZHAO Y, SWENSON K, SERGIO JJ, ARN JS, SACHS DH, SYKES M. Skin graft tolerance across a discordant xenogeneic barrier. Nat Med 1996:2:1211-1216.
118. STEINMAN L. The right stuff: Breaking through the xenotransplant barrier. Nat Med 1996:2:1185-1186.
119. GRITSCH HA, SYKES M. Host marrow has a competitive advantage that limits donor hematopoietic repopulation in mixed xenogeneic chimeras. Xenotransplantation 1996:3:312-320.
120. PIERPAOLI W, LESNIKOV V, LESNIKOV M, ARRIGHI S. Donor-derived plasma transferrin facilitates the engraftment of xenogeneic (rat) bone marrow in irradiated mice. Bone Marrow Transplant 1996:18:203-207.
121. LAMBRIGTS D, FRANSSEN C, MARTENS H, VAN CALSTER P, MEURISSE M, GEENEN V, CHARLET-RENARD C, DEWAELE A, COIGNOUL F, LAMY M, ALEXANDRE GPJ. Development of thymus autografts under the kidney capsule in the pig: A new "organ" for xenotransplantation. Xenotransplantation 1996:3:296-303.
122. MOHIUDDIN MM, SHEN Z, YOKOYAMA H, GOLDSTEIN C, DISESA VJ. Improved experimental cardiac xenograft survival with cyclophosphamide and intrathymic donor cells. Xenotransplantation 1996:3:260-263.
123. SCHUMACHER IK, NEWBERG MH, JACKSON JD, HAMMEL JM, RUBOCKI RJ, ENGELHARD VH, FOX IJ. Use of gene therapy to suppress the antigen-specific immune responses in mice to an HLA antigen. Transplantation 1996:62:831-836.
124. SHEN Z, MOHIUDDIN M, DISESA VJ. Fetal inoculation with donor cells in cardiac xenotransplantation. Ann Thorac Surg 1996:62:1360-1363.
125. BINHAZIM AA, RIZVI TA, COGHLAN LG, LEW K, SCHMIDT R, WONG PK. Rhesus thymic/liver xenografts in severe combined immonodeficient mice: Immunologic reconstitution and intrathymic infection with simian immunodeficiency virus. Lab Invest 1996:75:339-348.
126. ZANJANI ED, ALMEIDA-PORADA G, FLAKE AW. The human/ sheep xenograft model: A large animal model of human hematopoiesis. Int J Hematol 1996:63:179-192.
127. SYKES M. Hematopoietic cell transplantation for the induction of allo- and xenotolerance. Clin Transplant 1996:10:357-363.
128. HENEINE W, SWITZER WM. Highly sensitive and specific polymerase chain reaction assays for detection of baboon and pig cells following xenotransplantation in humans. Transplantation 1996:62:1360-1362.